Physician profile
Jason C Lee
NPI 1245227321
$2,501.40
in general payments reported to CMS, 2019-2025
15 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2021: $393 · 2022: $368 · 2023: $405 · 2024: $766 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $806.90 | 2021-2025 | Total30, Precision7, Clareon |
| Johnson & Johnson Vision Care, INC. | $232.17 | 2022-2023 | Acuvue |
| Sight Sciences, INC. | $219.25 | 2024-2025 | Omni Surgical System, Tearcare System |
| Allergan, INC. | $189.64 | 2019-2022 | |
| Lkc Technologies, INC. | $155.66 | 2024 | |
| Coopervision INC. | $136.34 | 2019-2024 | Misight Contact Lens |
| Maculogix, INC. | $120.43 | 2019 | |
| Oyster Point Pharma, INC. | $116.49 | 2023-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $107.90 | 2022-2025 | |
| Rxsight INC | $97.50 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Horizon Therapeutics Plc | $95.39 | 2021 | |
| Apellis Pharmaceuticals, INC. | $93.21 | 2024 | Syfovre |
| Glaukos Corporation | $62.85 | 2023 | |
| Bausch & Lomb Americas INC. | $49.09 | 2025 | Infuse |
| Abbvie INC. | $18.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.